Federated Hermes’s Decibel Therapeutics, Inc. Common Stock DBTX Stock Holding History

Federated Hermes’s Portfolio DBTX Stock Details DBTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-20,000	Closed	-$77K	–	2249
2023 Q2	$77K	Hold	20,000	–	–	﹤0.01%	1641
2023 Q1	$60.4K	Hold	20,000	–	–	﹤0.01%	1719
2022 Q4	$41K	Hold	20,000	–	–	﹤0.01%	1739
2022 Q3	$69K	Hold	20,000	–	–	﹤0.01%	1644
2022 Q2	$84K	Buy	20,000 +5,000	+33%	+$11.8K	﹤0.01%	1626
2022 Q1	$46K	Hold	15,000	–	–	﹤0.01%	1748
2021 Q4	$70K	Hold	15,000	–	–	﹤0.01%	1753
2021 Q3	$116K	Buy	15,000 +5,000	+50%	+$38.2K	﹤0.01%	1752
2021 Q2	$86K	Sell	10,000 -10,000	-50%	-$88.2K	﹤0.01%	1815
2021 Q1	$228K	Buy	+20,000	New	+$314K	﹤0.01%	1683

Other funds holding DBTX

ACA

Atlas Capital Advisors Jackson, Wyoming $914M AUM

Federated Hermes's DBTX Position: Q3 2023 in Review

Federated Hermes sold out of Decibel Therapeutics, Inc. Common Stock (DBTX) in Q3 2023, closing a stake of 20,000 shares — an estimated $77K sold.

Federated Hermes first reported a position in DBTX in Q1 2021 and held it in 10 quarters. The position peaked at $228K in Q1 2021. 1 fund tracked by Wall St. Rank holds DBTX as of Q3 2023.

Federated Hermes reported no remaining Decibel Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Federated Hermes sold 20,000 Decibel Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $77K.
Federated Hermes first reported a position in Decibel Therapeutics, Inc. Common Stock in Q1 2021 and held it in 10 quarters.
Federated Hermes's Decibel Therapeutics, Inc. Common Stock position peaked at $228K in Q1 2021.
1 fund tracked by Wall St. Rank held Decibel Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Federated Hermes's 13F filing for Q3 2023, filed 13 Nov 2023.